Risk in atrial fibrillation: left atrial function matters
Fecha
2019Language
en
Materia
Resumen
[No abstract available]
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke
Lip G.Y.H., Lane D.A., Lenarczyk R., Boriani G., Doehner W., Benjamin L.A., Fisher M., Lowe D., Sacco R.L., Schnabel R., Watkins C., Ntaios G., Potpara T. (2022)The management of patients with stroke is often multidisciplinary, involving various specialties and healthcare professionals. Given the common shared risk factors for stroke and cardiovascular disease, input may also be ... -
Ranolazine Added to Amiodarone Facilitates Earlier Conversion of Atrial Fibrillation Compared to Amiodarone-Only Therapy
Tsanaxidis N., Aidonidis I., Hatziefthimiou A., Daskalopoulou S.S., Giamouzis G., Triposkiadis F., Skoularigis I. (2017)Background: Amiodarone (AMIO) is for many years effectively used to control ventricular rate during atrial fibrillation (AF) and to convert it into sinus rhythm. However, due to its delayed onset of action, ranolazine ... -
Ranolazine depresses conduction of rapid atrial depolarizations in a beating rabbit heart model
Aidonidis I., Simopoulos V., Stravela S., Dipla K., Stamatiou R., Hatziefthimiou A., Molyvdas P.-A. (2021)Purpose: Previous clinical studies have shown that ranolazine (RAN) added to amiodarone (AMIO) might accelerate the termination of recent-onset atrial fibrillation. This study was undertaken to delineate possible mechanisms ...